S. Miraglia et al., Homogeneous cell- and bead-based assays for high throughput screening using fluorometric microvolume assay technology, J BIOMOL SC, 4(4), 1999, pp. 193-204
High throughput drug screening has become a critical component of the drug
discovery process. The screening of libraries containing hundreds of thousa
nds of compounds has resulted in a requirement for assays and instrumentati
on that are amenable to nonradioactive formats and that can be miniaturized
. Homogeneous assays that minimize upstream automation of the individual as
says are also preferable, Fluorometric microvolume assay technology (FMAT)
is a fluorescence-based platform for the development of nonradioactive cell
- and bead-based assays for HTS, This technology is plate format-independen
t, and while it was designed specifically for homogeneous ligand binding an
d immunological assays, it is amenable to any assay utilizing a fluorescent
cell or bead. The instrument fits on a standard laboratory bench and consi
sts of a laser scanner that generates a 1 mm(2) digitized image of a 100-mu
m deep section of the bottom of a microwell plate, The instrument is direc
tly compatible with a Zymark Twister(TM) (Zymark Corp., Hopkinton, MA) for
robotic loading of the scanner and unattended operation in HTS mode. Fluore
scent cells or beads at the bottom of the well are detected as localized ar
eas of concentrated fluorescence using data processing. Unbound flurophore
comprising the background signal is ignored, allowing for the development o
f a wide variety of homogeneous assays. The use of FMAT for peptide ligand
binding assays, immunofluorescence, apoptosis and cytotoxicity, and bead-ba
sed immunocapture assays is described here, along with a general overview o
f the instrument and software.